UBS Group
CCXI

UBS Group’s ChemoCentryx, Inc. CCXI Stock Holding History

UBS Group’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,000
Closed -$47K – 8546
2019
Q3 		$47K Buy
+7,000
New +$52.5K ﹤0.01% 6240

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS Group's CCXI Position: Q4 2022 in Review

UBS Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 115,482 shares — an estimated $5.97M sold.

UBS Group first reported a position in CCXI in Q4 2014 and held it in 29 quarters. The position peaked at $36.2M in Q1 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • UBS Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 115,482 ChemoCentryx, Inc. shares in Q4 2022, an estimated $5.97M.
  • UBS Group first reported a position in ChemoCentryx, Inc. in Q4 2014 and held it in 29 quarters.
  • UBS Group's ChemoCentryx, Inc. position peaked at $36.2M in Q1 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.